Clinical Impact and Risk Factors of Nonsusceptibility to Third-Generation Cephalosporins Among Hospitalized Adults with Monomicrobial Enterobacteriaceae Bacteremia in Southern Taiwan: A Multicenter Study

References

• Oliveira MC, Oliveira CR, Goncalves KV, Santos MS, Tardelli AC, Nobre VA Jr. Enterobacteriaceae resistant to third generation cephalosporins upon hospital admission: risk factors and clinical outcomes. Braz J Infect Dis. 2015;19(3):239–245. doi:10.1016/j.bjid.2015.01.00625892313
   PubMed Web of Science ®Google Scholar
• Liu LH, Wang NY, Wu AY, Lin CC, Lee CM, Liu CP. Citrobacter freundii bacteremia: risk factors of mortality and prevalence of resistance genes. J Microbiol Immunol Infect. 2018;51(4):565–572. doi:10.1016/j.jmii.2016.08.01628711438
   PubMedGoogle Scholar
• Syue LS, Tang HJ, Hung YP, et al. Bloodstream infections in hospitalized adults with dengue fever: clinical characteristics and recommended empirical therapy. J Microbiol Immunol Infect. 2019;52(2):225–232. doi:10.1016/j.jmii.2018.11.00330528336
   PubMedGoogle Scholar
• Erlanger D, Assous MV, Wiener-Well Y, Yinnon AM, Ben-Chetrit E. Clinical manifestations, risk factors and prognosis of patients with Morganella morganii sepsis. J Microbiol Immunol Infect. 2019;52:443–448. doi:10.1016/j.jmii.2017.08.01028919283
   PubMedGoogle Scholar
• Huang YT, Jiang JY, Hsu MS, Hsu HS, Liao CH, Hsueh PR. The prevalence of rectal carriage of Klebsiella pneumoniae amongst diabetic patients and their clinical relevance in Taiwan: a five-year prospective study. J Microbiol Immunol Infect. 2018;51(4):510–518. doi:10.1016/j.jmii.2017.05.00928693930
   PubMedGoogle Scholar
• Du F, Wei DD, Wan LG, Cao XW, Zhang W, Liu Y. Evaluation of ompK36 allele groups on clinical characteristics and virulence features of Klebsiella pneumoniae from bacteremia. J Microbiol Immunol Infect. 2019;52(5):779–787. doi:10.1016/j.jmii.2018.08.01830348614
   PubMedGoogle Scholar
• Lee CC, Lee CH, Hong MY, Hsieh CC, Tang HJ, Ko WC. Propensity-matched analysis of the impact of extended-spectrum beta-lactamase production on adults with community-onset Escherichia coli, Klebsiella species, and Proteus mirabilis bacteremia. J Microbiol Immunol Infect. 2018;51(4):519–526. doi:10.1016/j.jmii.2017.05.00628698042
   PubMedGoogle Scholar
• Yang TY, Lu PL, Tseng SP. Update on fosfomycin-modified genes in Enterobacteriaceae. J Microbiol Immunol Infect. 2019;52(1):9–21. doi:10.1016/j.jmii.2017.10.00629198952
   PubMedGoogle Scholar
• Hung WT, Cheng MF, Tseng FC, et al. Bloodstream infection with extended-spectrum beta-lactamase–producing Escherichia coli: the role of virulence genes. J Microbiol Immunol Infect. 2019;52(6):947–955. doi:10.1016/j.jmii.2019.03.00531076319
   PubMedGoogle Scholar
• Chen CY, Hsieh PH, Chang CY, et al. Molecular epidemiology of the emerging ceftriaxone resistant non-typhoidal Salmonella in southern Taiwan. J Microbiol Immunol Infect. 2019;52(2):289–296. doi:10.1016/j.jmii.2018.08.00730201133
   PubMedGoogle Scholar
• Yang JJ, Wang JT, Cheng A, Chuang YC, Sheng WH. Impact of broad-spectrum antimicrobial treatment on the ecology of intestinal flora. J Microbiol Immunol Infect. 2018;51(5):681–687. doi:10.1016/j.jmii.2016.12.00928693929
   PubMedGoogle Scholar
• Martelius T, Jalava J, Karki T, et al. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999–2013: trends, patient characteristics and mortality. Infect Dis (Lond). 2016;48(3):229–234. doi:10.3109/23744235.2015.110913526577519
   PubMed Web of Science ®Google Scholar
• Stewardson AJ, Allignol A, Beyersmann J, et al. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study. Euro Surveill. 2016;21(33):21. doi:10.2807/1560-7917.ES.2016.21.33.30319
   Google Scholar
• de Kraker ME, Davey PG, Grundmann H, Opal SM. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011;8(10):e1001104. doi:10.1371/journal.pmed.100110422022233
   PubMed Web of Science ®Google Scholar
• Kang CI, Kim SH, Park WB, et al. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Clin Infect Dis. 2004;39(6):812–818. doi:10.1086/42338215472813
   PubMed Web of Science ®Google Scholar
• Lin WP, Huang YS, Wang JT, Chen YC, Chang SC. Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan. BMC Infect Dis. 2019;19(1):245. doi:10.1186/s12879-019-3880-z30866828
   PubMed Web of Science ®Google Scholar
• The Clinical and Laboratory Standards InstituteI. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100. 28th ed.
   Google Scholar
• Lee CC, Lee CH, Hong MY, Tang HJ, Ko WC. Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia. Crit Care. 2017;21(1):119. doi:10.1186/s13054-017-1696-z28545484
   PubMed Web of Science ®Google Scholar
• Lee CC, Lee CH, Yang CY, Hsieh CC, Tang HJ, Ko WC. Beneficial effects of early empirical administration of appropriate antimicrobials on survival and defervescence in adults with community-onset bacteremia. Crit Care. 2019;23(1):363. doi:10.1186/s13054-019-2632-131747950
   PubMed Web of Science ®Google Scholar
• David N. Selected pharmacologic features of antimicrobial agents. Sanford Guide Antimicrobial Ther. 2009;78–82.
   Google Scholar
• Lee CC, Lee NY, Yan JJ, et al. Bacteremia due to extended-spectrum-β-lactamase-producing Enterobacter cloacae: role of carbapenem therapy. Antimicrob Agents Chemother. 2010;54(9):3551–3556. doi:10.1128/AAC.00055-1020547798
   PubMed Web of Science ®Google Scholar
• Vasudevan A, Mukhopadhyay A, Li J, Yuen EG, Tambyah PA. A prediction tool for nosocomial multi-drug resistant gram-negative bacilli infections in critically ill patients – prospective observational study. BMC Infect Dis. 2014;14(1):615. doi:10.1186/s12879-014-0615-z25420613
   PubMed Web of Science ®Google Scholar
• Lee -C-C, Yang C-Y, Su B-A, et al. The hypotension period after initiation of appropriate antimicrobial administration is crucial for survival of bacteremia patients initially experiencing severe sepsis and septic shock. J Clin Med. 2020;9(8):2617. doi:10.3390/jcm9082617
   Web of Science ®Google Scholar
• Schellevis FG, van der Velden J, van de Lisdonk E, van Eijk JT, van Weel C. Comorbidity of chronic diseases in general practice. J Clin Epidemiol. 1993;46(5):469–473. doi:10.1016/0895-4356(93)90024-U8501473
   PubMed Web of Science ®Google Scholar
• Lesens O, Methlin C, Hansmann Y, et al. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol. 2003;24:890–896.14700403
   PubMed Web of Science ®Google Scholar
• Noguchi T, Matsumura Y, Yamamoto M, Nagao M, Takakura S, Ichiyama S. Clinical and microbiologic characteristics of cefotaxime-non-susceptible Enterobacteriaceae bacteremia: a case control study. BMC Infect Dis. 2017;17(1):44. doi:10.1186/s12879-016-2150-628061869
   PubMed Web of Science ®Google Scholar
• Rottier WC, Bamberg YRP, Dorigo-Zetsma JW, van der Linden PD, Ammerlaan HSM, Bonten MJM. Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant Enterobacteriaceae bacteremia in patients with sepsis. Clin Infect Dis. 2015;60(11):1622–1630. doi:10.1093/cid/civ12125694654
   PubMed Web of Science ®Google Scholar
• Chu SM, Hsu JF, Lai MY, et al. Risk factors of initial inappropriate antibiotic therapy and the impacts on outcomes of neonates with gram-negative bacteremia. Antibiotics (Basel). 2020;9.
   Web of Science ®Google Scholar
• Usai D, Donadu M, Bua A, et al. Enhancement of antimicrobial activity of pump inhibitors associating drugs. J Infect Dev Ctries. 2019;13(2):162–164. doi:10.3855/jidc.1110232036352
   PubMed Web of Science ®Google Scholar
• Bohnert JA, Schuster S, Fähnrich E, Trittler R, Kern WV. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF). J Antimicrob Chemother. 2007;59(6):1216–1222. doi:10.1093/jac/dkl42617062614
   PubMed Web of Science ®Google Scholar
• Somboro AM, Osei Sekyere J, Amoako DG, et al. In vitro potentiation of carbapenems with tannic acid against carbapenemase-producing enterobacteriaceae: exploring natural products as potential carbapenemase inhibitors. J Appl Microbiol. 2019;126(2):452–467. doi:10.1111/jam.1414130365206
   PubMed Web of Science ®Google Scholar
• Donadu MG, Trong Le N, Ho D V, et al. Phytochemical compositions and biological activities of essential oils from the leaves, rhizomes and whole plant of Hornstedtia bella škorničk. Antibiotics (Basel). 2020;9(6):334. doi:10.3390/antibiotics9060334
   Web of Science ®Google Scholar
• Le NT, Donadu MG, Ho DV, et al. Biological activities of essential oil extracted from leaves of Atalantia sessiflora Guillauminin Vietnam. J Infect Dev Ctries. 2020;14(9):1054–1064. doi:10.3855/jidc.1246933031096
   PubMed Web of Science ®Google Scholar
• Trong Le N, Viet Ho D, Quoc Doan T, et al. Biological activities of essential oils from leaves of Paramignya trimera (Oliv.) Guillaum and Limnocitrus littoralis (Miq.) swingle. Antibiotics (Basel). 2020;9(4):207. doi:10.3390/antibiotics9040207
   Web of Science ®Google Scholar
• Patterson JE, McElmeel L, Wiederhold NP. In vitro activity of essential oils against gram-positive and gram-negative clinical isolates, including carbapenem-resistant Enterobacteriaceae. Open Forum Infect Dis. 2019;6(12):ofz502. doi:10.1093/ofid/ofz50231844638
   PubMed Web of Science ®Google Scholar